Abstract

BackgroundAs most genital chlamydia infections are asymptomatic, screening is the main way to detect and cases for treatment. We undertook a systematic review of studies assessing the efficacy of interventions for increasing the uptake of chlamydia screening in primary care.MethodsWe reviewed studies which compared chlamydia screening in the presence and the absence of an intervention. The primary endpoints were screening rate or total tests.ResultsWe identified 16 intervention strategies; 11 were randomised controlled trials and five observational studies, 10 targeted females only, five both males and females, and one males only. Of the 15 interventions among females, six were associated with significant increases in screening rates at the 0.05 level including a multifaceted quality improvement program that involved provision of a urine jar to patients at registration (44% in intervention clinics vs. 16% in the control clinic); linking screening to routine Pap smears (6.9% vs. 4.5%), computer alerts for doctors (12.2% vs. 10.6%); education workshops for clinic staff; internet-based continuing medical education (15.5% vs. 12.4%); and free sexual health consultations (16.8% vs. 13.2%). Of the six interventions targeting males, two found significant increases including the multifaceted quality improvement program in which urine jars were provided to patients at registration (45% vs. 15%); and the offering by doctors of a test to all presenting young male clients, prior to consultation (29 vs. 4%).ConclusionsInterventions that promoted the universal offer of a chlamydia test in young people had the greatest impact on increasing screening in primary care.

Highlights

  • As most genital chlamydia infections are asymptomatic, screening is the main way to detect and cases for treatment

  • Review strategy A publication was considered for inclusion if it reported on the evaluation of an intervention to increase chlamydia screening rates in a primary care clinic, through a comparison with chlamydia screening rates in a control group or control time period

  • Studies were conducted in Australia (n = 5), the US (n = 5), the UK, Scotland, Belgium, Denmark and New Zealand (NZ) (1 each)

Read more

Summary

Introduction

As most genital chlamydia infections are asymptomatic, screening is the main way to detect and cases for treatment. As over 80% of infections are asymptomatic, screening on the basis of epidemiological risk factors such as age and sexual history is the main way to detect cases [1,2]. Despite the central role of primary care in chlamydia management, the proportion of sexually active young people attending these clinics who are offered screening at the time of their visit is low in many countries ranging from 3.3% of 15-24 year females and 1.0% of males in the South East of England in 2006/ 07 [9]: and 12.5% of young sexually active females and 3.7% of males in Australia in 2008 [7]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.